Bilimsel Yayınlar

Yabancı Dergilerde Basılmış Makaleler

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. N Engl J Med. 2020 Dec 3;383(23):2219-2229.

Yazının Tamamı İçin Tıklayın
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-KD study investigators.Am J Nephrol. 2019;50(5):333-344.

Yazının Tamamı İçin Tıklayın
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-KD study investigators.Am J Nephrol. 2019;50(5):333-344.

Yazının Tamamı İçin Tıklayın
Primary Amyloidosis with Gastric Involvement
Primary Amyloidosis with Gastric Involvement. Borazan S, Coşkun A, Yavaşoğlu İ, Yeniçerioğlu Y, Meteoğlu İ, Hadi Yaşa M, Karaoğlu AÖ. Euroasian J Hepatogastroenterol. 2014 Jul-Dec;4(2):107-109.

Yazının Tamamı İçin Tıklayın
The effect of hemodialysis on the body composition and cardiovascular disease markers in recently diagnosed end stage renal disease patients
The effect of hemodialysis on the body composition and cardiovascular disease markers in recently diagnosed end stage renal disease patients. Cakiroglu U, Akdam H, Eryilmaz U, Akgullu C, Ozbek O, Büyüköztürk AK, Akar H, Yenicerioglu Y. Rev Assoc Med Bras (1992). 2018 Apr;64(4):354-360.

Yazının Tamamı İçin Tıklayın
The effects of single hemodialysis session on arterial stiffness in hemodialysis patients
The effects of single hemodialysis session on arterial stiffness in hemodialysis patients. Öğünç H, Akdam H, Alp A, Gencer F, Akar H, Yeniçerioğlu Y. Hemodial Int. 2015 Jul;19(3):463-71.

Yazının Tamamı İçin Tıklayın
Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study. Yeniçerioğlu Y, Akdam H, Dursun B, Alp A, Sağlam Eyiler F, Akın D, Gün Y, Hüddam B, Batmazoğlu M, Gibyeli Genek D, Pirinççi S, Ersoy İR, Üzüm A, Soypaçacı Z, Tanrısev M, Çolak H, Demiral Sezer S, Bozkurt G, Akyıldız UO, Akyüz Ünsal Aİ, Ünübol M, Uslu M, Eryılmaz U, Günel C, Meteoğlu İ, Yavaşoğlu İ, Ünsal A, Akar H, Okyay P. Ren Fail. 2017 Nov;39(1):104-111.

Yazının Tamamı İçin Tıklayın
Assessment of volume status and arterial stiffness in chronic kidney disease
Assessment of volume status and arterial stiffness in chronic kidney disease. Akdam H, Öğünç H, Alp A, Özbek Ö, Ömürlü İK, Yeniçerioğlu Y, Akar H. Ren Fail. 2014 Feb;36(1):28-34.

Yazının Tamamı İçin Tıklayın
The primary patency of drug-eluting balloon versus conventional balloon angioplasty in hemodialysis patients with arteriovenous fistula stenoses
The primary patency of drug-eluting balloon versus conventional balloon angioplasty in hemodialysis patients with arteriovenous fistula stenoses. Çildağ MB, Köseoğlu ÖF, Akdam H, Yeniçerioğlu Y. Jpn J Radiol. 2016 Oct;34(10):700-704.

Yazının Tamamı İçin Tıklayın
Acute kidney injury after near drowning: The way from the beach to hemodialysis
Acute kidney injury after near drowning: The way from the beach to hemodialysis. Alp A, Akdam H, Meteoğlu İ, Ünsal A, Akar H, Yeniçerioğlu Y. Hemodial Int. 2016 Jan;20(1):E1-4.

Yazının Tamamı İçin Tıklayın
Is bullous skin lesion a risk factor for renal amyloidosis in patients with familial mediterranean fever?
Is bullous skin lesion a risk factor for renal amyloidosis in patients with familial mediterranean fever? Sargin G, Alp A, Akdam H, Akar H, Yenicerioglu Y. Indian J Nephrol. 2013 Nov;23(6):469-70.

Yazının Tamamı İçin Tıklayın
Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report.
Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report. Alp A, Akdam H, Akar H, Koseoglu K, Ozkul A, Meteoglu I, Yenicerioglu Y. Nefrologia. 2014 Nov 17;34(6):789-96.

Yazının Tamamı İçin Tıklayın
Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia
10) Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Duman N, Uyanik A, Unsal A, Sezer S, Camsari T, Cirit M, Yilmaz ME, Altun B, Duranay M, Yildiz A, Sahin I, Dogukan A, Ustundag S, Karayaylali I, Kahveci A, Sindel S, Kiykim AA, Yenicerioglu Y, Akbas E, Ozdener F.Clin Kidney J. 2014 Oct;7(5):464-9.

Yazının Tamamı İçin Tıklayın
Effects of N-acetylcysteine on radiocontrast nephropathy in rats.
Effects of N-acetylcysteine on radiocontrast nephropathy in rats. Yenicerioglu Y, Yilmaz O, Sarioglu S, Ormen M, Akan P, Celik A, Camsari T.Scand J Urol Nephrol. 2006;40(1):63-9

Yazının Tamamı İçin Tıklayın
Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy.
Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy. Barlak A, Akar H, Yenicerioglu Y, Yenisey C, Meteoğlu I, Yilmaz O.Ren Fail. 2010;32(8):992-9.

Yazının Tamamı İçin Tıklayın
Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis.
Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis. Yeniçerioglu Y, Uzelce O, Akar H, Kolatan E, Yilmaz O, Yenisey C, Sarioglu S, Meteoglu I.Ren Fail. 2010;32(9):1095-102.

Yazının Tamamı İçin Tıklayın
Malnutrition due to bisphosphonate-related osteonecrosis of the jaw in a chronic dialysis patient: case report.
Malnutrition due to bisphosphonate-related osteonecrosis of the jaw in a chronic dialysis patient: case report. Coskun Akar G, Efeoglu C, Alp A, Koseoglu K, Erol H, Yenicerioglu Y, Akar H.Ren Fail. 2013 Aug;35(7):1008-12

Yazının Tamamı İçin Tıklayın
Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients.
Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients. Sifil A, Mermut C, Yenicerioglu Y, Cavdar C, Gumustekin M, Celik A, Yuksel F, Camsari T.Adv Perit Dial. 2003;19:28-30.

Yazının Tamamı İçin Tıklayın
International study on Sagliker syndrome and uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic kidney disease patients.
International study on Sagliker syndrome and uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic kidney disease patients. Sagliker Y, Acharya V, Ling Z, Golea O, Sabry A, Eyupoglu K, Ookalkar DS, Tapiawala S, Durugkar S, Khetan P, Capusa C, Univar R, Yildiz I, Cengiz K, Bali M, Ozkaynak PS, Sagliker HS, Paylar N, Adam SM, Balal M, Paydas S, Demirhan O, Tasdemir D, Ben Maiz H, Redulescu D, Garneata L, Mircescu G, Hong-Liang R, Lun L, Yildizer K, Emir I, Yuksekgonul M, Yenicerioglu Y, Akar H, Sagliker C, Esenturk M, Kiralp N.J Ren Nutr. 2008 Jan;18(1):114-7.

Yazının Tamamı İçin Tıklayın
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures Alper O Onbasili 1, Yavuz Yeniceriglu, Pinar Agaoglu, Aslihan Karul, Tarkan Tekten, Harun Akar, Guzel Discigil. Heart . 2007 Jun;93(6):698-702.

Yazının Tamamı İçin Tıklayın
Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis
Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis. Yeniçerioglu Y, Kefi A, Aslan G, Cavdar C, Esen AA, Camsari T, Celebi I.BJU Int. 2002 Sep;90(4):442-5.

Yazının Tamamı İçin Tıklayın
Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y. J Thromb Thrombolysis. 2008 Oct;26(2):97-102.

Yazının Tamamı İçin Tıklayın
.
Effects of haemodialysis on pulmonary clearance of Tc-99m diethylene triamine pentaacetate (DTPA).
Effects of haemodialysis on pulmonary clearance of Tc-99m diethylene triamine pentaacetate (DTPA). Yeniçerioglu Y, Sapak Sahin S, Capa G, Abadoglu O, Camsan T, Altan R, Başar M, Durak H, Uçan ES.Scand J Urol Nephrol. 2000 Apr;34(2):126-30.

Yazının Tamamı İçin Tıklayın
Outcome of renal transplantation: 7-year experience.
Outcome of renal transplantation: 7-year experience. Celik A, Sifil A, Cavdar C, Erkan N, Yeniçerioglu Y, Bora S, Gulay H, Camsari T.Transplant Proc. 2001 Aug;33(5):2657-9.

Yazının Tamamı İçin Tıklayın
The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats.
The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats. Ersoy R, Celik A, Yilmaz O, Sarioglu S, Sis B, Akan P, Yenicerioglu Y, Ormen M, Camsari T.Perit Dial Int. 2007 Jul-Aug;27(4):424-31.

Yazının Tamamı İçin Tıklayın
Is survival enough for quality of life in Sagliker Syndrome-uglifying human face appearances in chronic kidney disease?
Is survival enough for quality of life in Sagliker Syndrome-uglifying human face appearances in chronic kidney disease? Sagliker Y, Acharya V, Golea O, Sabry A, Bali M, Eyupoglu K, Ookalkar D, Tapiawala S, Durugkar S, Khetan P, Capusa C, Univar R, Yildiz I, Cengiz K, Akar H, Yenicerioglu Y, Sagliker Ozkaynak P, Sabit Sagliker H, Paylar N.J Nephrol. 2008 Mar-Apr;21 Suppl 13:S134-8.

Yazının Tamamı İçin Tıklayın
The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Cavdar C, Temiz A, Yeniçerioğlu Y, Calişkan S, Celik A, Sifil A, Onvural B, Camsari T. Scand J Urol Nephrol. 2003;37(1):77-82.

Yazının Tamamı İçin Tıklayın
Cardiac cyclic variation of integrated backscatter in hypertension and dialysis patients.
Cardiac cyclic variation of integrated backscatter in hypertension and dialysis patients. Akar H, Ceyhan C, Yenicerioglu Y, Keven K, Onbasili A, Tekten T.J Nephrol. 2004 Mar-Apr;17(2):270-4.

Yazının Tamamı İçin Tıklayın
Severe, long-lasting symptoms from doxycycline-induced esophageal injury.
Severe, long-lasting symptoms from doxycycline-induced esophageal injury. Tankurt IE, Akbaylar H, Yenicerioglu Y, Simsek I, Gonen O.Endoscopy. 1995 Oct;27(8):626.

Yazının Tamamı İçin Tıklayın
Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence.
Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence. Birlik M, Tunca M, Hizli N, Soytürk M, Yeniçerioğlu Y, Ozcan MA, El O.Clin Rheumatol. 1998;17(5):397-9.

Yazının Tamamı İçin Tıklayın